APA (7th ed.) Citation

TK, C., BN, L., AK, O., BR, D., CS, C., IM, C., . . . CL, P. (2025). Maternal Health and Safety Outcomes of Prenatal Myostatin Inhibition in Osteogenesis Imperfecta Mice. Endocrinology, 166(7), . https://doi.org/10.1210/endocr/bqaf080

Chicago Style (17th ed.) Citation

TK, Crawford, et al. "Maternal Health and Safety Outcomes of Prenatal Myostatin Inhibition in Osteogenesis Imperfecta Mice." Endocrinology 166, no. 7 (2025). https://doi.org/10.1210/endocr/bqaf080.

MLA (9th ed.) Citation

TK, Crawford, et al. "Maternal Health and Safety Outcomes of Prenatal Myostatin Inhibition in Osteogenesis Imperfecta Mice." Endocrinology, vol. 166, no. 7, 2025, https://doi.org/10.1210/endocr/bqaf080.